Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-HDS in B-cell Lymphoma with CNS Involvement
NCT00801216Phase 2Completed
- Start
- Jan 2007
- Primary completion
- Jan 2013
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liposomal cytarabine in B cell lymphoma. Primary endpoint: Event-free Survival at 2 years. Started Jan 2007; status: completed.
02
Drugs
liposomal cytarabine
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT00801216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801216.